Your browser doesn't support javascript.
loading
Why and How Should We Integrate Biomarkers into Complex Trials? A Discussion on Paradigms and Clinical Research Strategies.
Musial, Frauke; Mist, Scott; Warber, Sara; Kreitzer, Mary Jo; Ritenbaugh, Cheryl; Kessler, Christian.
Afiliação
  • Musial F; National Research Center in Complementary and Alternative Medicine (NAFKAM), Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway, frauke.musial@uit.no.
  • Mist S; School of Nursing, Oregon Health and Science University, Portland, Oregon, USA.
  • Warber S; Department of Family Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Kreitzer MJ; Earl E. Bakken Center for Spirituality and Healing, University of Minnesota, Minneapolis, Minnesota, USA.
  • Ritenbaugh C; Department of Family and Community Medicine, University of Arizona, Tucson, Arizona, USA.
  • Kessler C; Department of Internal and Complementary Medicine, Immanuel Hospital and Institute of Social Medicine, Epidemiology and Health Economics, Charité - University Medical Center, Berlin, Germany.
Complement Med Res ; 26(5): 343-352, 2019.
Article em En | MEDLINE | ID: mdl-30974436
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa / Terapias Complementares / Biomarcadores / Ensaios Clínicos como Assunto Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa / Terapias Complementares / Biomarcadores / Ensaios Clínicos como Assunto Idioma: En Ano de publicação: 2019 Tipo de documento: Article